Istituti Clinici Scientifici Maugeri SpA
icsmaugeri.itTotal trials
112
Active
49
Phase 3
0
Total enrollment
18,605
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 5 of 5 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Pembrolizumab | — | — | — | — | — | 2 | |
| Cisplatin | — | — | — | — | — | 1 | |
| Docetaxel | — | — | — | — | — | 1 | |
| Carboplatin | — | — | — | — | — | 1 | |
| Prismatic adaptation and electric stimulation | — | — | — | — | — | 1 |
Next readouts
- 2026-07-15
- 2026-11
- 2026-12
Top conditions
- Breast Cancer12
- COPD6
- Asthma5
- Parkinson Disease5
- Stroke5
- Healthy Volunteers4
- Multiple Sclerosis3
- Rehabilitation3
Frequently asked questions about Istituti Clinici Scientifici Maugeri SpA
- How many clinical trials does Istituti Clinici Scientifici Maugeri SpA have on ClinicalTrials.gov?
- Istituti Clinici Scientifici Maugeri SpA is listed as the lead sponsor on 112 clinical trials in ClinicalTrials.gov, 49 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Istituti Clinici Scientifici Maugeri SpA's trials are in Phase 3?
- 0 of Istituti Clinici Scientifici Maugeri SpA's trials are in Phase 3, spread across 5 active drug programs.
- What therapeutic areas does Istituti Clinici Scientifici Maugeri SpA focus on?
- Istituti Clinici Scientifici Maugeri SpA's most-studied conditions on ClinicalTrials.gov are Breast Cancer, COPD, Asthma, Parkinson Disease, Stroke.
- When are Istituti Clinici Scientifici Maugeri SpA's next clinical trial readouts?
- Istituti Clinici Scientifici Maugeri SpA has 3 upcoming primary-completion readouts tracked here; the soonest is “Prismatic Lenses and tDCS in Neglect”, expected around 2026-07-15.